3'-Deoxy-4-O-methylepisappanolCAS# 1052714-12-1 |
2D Structure
- 3'-Deoxy-4-O-methylsappanol
Catalog No.:BCN3675
CAS No.:112408-68-1
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 1052714-12-1 | SDF | Download SDF |
PubChem ID | 71463283 | Appearance | Powder |
Formula | C17H18O5 | M.Wt | 302.3 |
Type of Compound | Flavonoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (3R,4R)-3-[(4-hydroxyphenyl)methyl]-4-methoxy-2,4-dihydrochromene-3,7-diol | ||
SMILES | COC1C2=C(C=C(C=C2)O)OCC1(CC3=CC=C(C=C3)O)O | ||
Standard InChIKey | NRDMATSOBGRQDO-IAGOWNOFSA-N | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. 3'-Deoxy-4-O-methylepisappanol has antioxidant activity. 2. 3'-Deoxy-4-O-methylepisappanol exhibits significant neuroprotective activity against glutamate-induced toxicity at concentrations ranging from 0.1 microM to 10 microM. |
Targets | LDL | ROS |
3'-Deoxy-4-O-methylepisappanol Dilution Calculator
3'-Deoxy-4-O-methylepisappanol Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.308 mL | 16.5399 mL | 33.0797 mL | 66.1594 mL | 82.6993 mL |
5 mM | 0.6616 mL | 3.308 mL | 6.6159 mL | 13.2319 mL | 16.5399 mL |
10 mM | 0.3308 mL | 1.654 mL | 3.308 mL | 6.6159 mL | 8.2699 mL |
50 mM | 0.0662 mL | 0.3308 mL | 0.6616 mL | 1.3232 mL | 1.654 mL |
100 mM | 0.0331 mL | 0.1654 mL | 0.3308 mL | 0.6616 mL | 0.827 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 5'-Methoxylariciresinol
Catalog No.:BCN7012
CAS No.:105256-12-0
- SBE 13 HCl
Catalog No.:BCC6408
CAS No.:1052532-15-6
- Virosine B
Catalog No.:BCN6742
CAS No.:1052228-70-2
- WEB 2086
Catalog No.:BCC7335
CAS No.:105219-56-5
- PSB 06126
Catalog No.:BCC7417
CAS No.:1052089-16-3
- PSB 0739
Catalog No.:BCC6095
CAS No.:1052087-90-7
- Q94 hydrochloride
Catalog No.:BCC6281
CAS No.:1052076-77-3
- 9-Oxoageraphorone
Catalog No.:BCN5866
CAS No.:105181-06-4
- AC 264613
Catalog No.:BCC3952
CAS No.:1051487-82-1
- GSK1349572 sodiuM salt
Catalog No.:BCC6407
CAS No.:1051375-19-9
- S/GSK1349572
Catalog No.:BCC2138
CAS No.:1051375-16-6
- GSK744 (S/GSK1265744)
Catalog No.:BCC3888
CAS No.:1051375-10-0
- Ganodermatriol
Catalog No.:BCC8177
CAS No.:105300-28-5
- Aloeresin D
Catalog No.:BCN2850
CAS No.:105317-67-7
- Neocaesalpin O
Catalog No.:BCN7266
CAS No.:1053189-53-9
- 5,7,4'-Tri-O-methylcatechin
Catalog No.:BCN3951
CAS No.:105330-59-4
- Tanshinlactone
Catalog No.:BCN5867
CAS No.:105351-70-0
- Tyrphostin 9
Catalog No.:BCC4471
CAS No.:10537-47-0
- Shuterin
Catalog No.:BCN8068
CAS No.:105377-77-3
- Bis(3-ethyl-5-methyl-4-maleimidophenyl)methane
Catalog No.:BCC8881
CAS No.:105391-33-1
- Spiroxatrine
Catalog No.:BCC6728
CAS No.:1054-88-2
- Tamoxifen
Catalog No.:BCN1634
CAS No.:10540-29-1
- 7-Epitaxol
Catalog No.:BCN2514
CAS No.:105454-04-4
- Risedronate
Catalog No.:BCC4711
CAS No.:105462-24-6
Antioxidant properties of benzylchroman derivatives from Caesalpinia sappan L. against oxidative stress evaluated in vitro.[Pubmed:20105050]
J Enzyme Inhib Med Chem. 2010 Oct;25(5):608-14.
The antioxidant activity of extracts from Caesalpinia sappan L. (CSL) was studied in vitro by evaluating the total phenolics, measuring the antioxidant activity by TEAC, measuring the scavenging effects on reactive oxygen species (ROS) and on reactive nitrogen species (RNS), and measuring the inhibitory effect on Cu(2+)-induced human low-density lipoprotein (LDL) oxidation. The CSL extracts were found to have a potent scavenging activity against all of the reactive species tested, as well as an inhibitory effect on LDL oxidation, especially in the ethyl acetate (EA) fraction. Therefore, we isolated and identified benzylchroman derivatives sappanchalcone (1) and 3'-deoxy-4-O-methylepisappanol (2) from the EA fraction of CSL and their antioxidant activities were evaluated. The studied CSL extracts and the compounds 1 and 2 were revealed to be very effective against the evaluated pro-oxidant species, including ROS and RNS.
Protective effects of 3'-deoxy-4-O-methylepisappanol from Caesalpinia sappan against glutamate-induced neurotoxicity in primary cultured rat cortical cells.[Pubmed:19777498]
Phytother Res. 2010 Mar;24(3):463-5.
To examine the neuroprotective effects of Caesalpinia sappan L., we tested its protection against the glutamate-induced neurotoxicity in primary cortical cultured neurons. We found that an aqueous extract of this medicinal plant exhibited significant protection against glutamate-induced toxicity in primary cultured rat cortical cells. In order to clarify the neuroprotective mechanism(s) of this observed effect, isolation was performed to seek and identify active fractions and components. By such fractionation, two known compounds - sappanchalcone and 3'-deoxy-4-O-methylepisappanol - were isolated from the methanol extracts from the air-dried and chipped C. sappan. Among these two compounds, 3'-deoxy-4-O-methylepisappanol exhibited significant neuroprotective activities against glutamate-induced toxicity, exhibiting cell viability of about 50%, at concentrations ranging from 0.1 microM to 10 microM. Therefore, the neuroprotective effect of C. sappan might be due to the inhibition of glutamate-induced toxicity by the protosappanin derivative it contains.